新冠肺炎全球大流行以來,截至2020年4月3日,全球已有972,303個確診案例,有50,322個個案因病死亡;Dr. Kim及其研究團隊針對116位確診案例的檢體;篩檢其他呼吸道常見致病病毒或病菌, 結果發現有20.7%的個案同時感染其他呼吸道常見致病病毒或病菌,此比例比先前研究報告要來的高,由於此研究個案均來自北加州,加上研究個案數不算太大,因此,需更多研究結果來確定;在尚未有效治療新冠肺炎的藥物之前,篩檢其他呼吸道常見致病病毒或病菌,對臨床並無太大幫助。

(財團法人國家衛生研究院 蔡慧如博士摘要整理)

As of April 3, 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had caused 972 303 cases of coronavirus disease 2019 (COVID-19) and 50 322 deaths worldwide.1 Early reports from China suggested that co-infection with other respiratory pathogens was rare.2 If this were the case, patients positive for other pathogens might be assumed unlikely to have SARS-CoV-2. The Centers for Disease Control and Prevention endorsed testing for other respiratory pathogens, suggesting that evidence of another infection could aid the evaluation of patients with potential COVID-19 in the absence of widely available rapid testing for SARS-CoV-2.3 Here we report on co-infection rates between SARS-CoV-2 and other respiratory pathogens in Northern California.

Author:David Kim, James Quinn,Benjamin Pinsky,et al.
原文連結:https://jamanetwork.com/journals/jama/fullarticle/2764787